1H NMR Study on the Binding of Pin1 Trp-Trp Domain with Phosphothreonine Peptides*

René WintjensDagger , Jean-Michel WieruszeskiDagger , Hervé DrobecqDagger , Pierre Rousselot-PailleyDagger , Luc Buée§, Guy LippensDagger , and Isabelle LandrieuDagger

From the Dagger  Institut de Biologie de Lille, Institut Pasteur de Lille, CNRS-UMR 8525, 1 rue du Professeur Calmette, BP 447, Lille 59021 and the § Unité INSERM 422, Place de Verdun, Lille 59045, France

Received for publication, November 14, 2000, and in revised form, March 29, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The recent crystal structure of Pin1 protein bound to a doubly phosphorylated peptide from the C-terminal domain of RNA polymerase II revealed that binding interactions between Pin1 and its substrate take place through its Trp-Trp (WW) domain at the level of the loop Ser11-Arg12 and the aromatic pair Tyr18-Trp29, and showed a trans conformation for both pSer-Pro peptide bonds. However, the orientation of the ligand in the aromatic recognition groove still could be sequence-specific, as previously observed in SH3 domains complexed by peptide ligands or for different class of WW domains (Zarrinpar, A., and Lim, W. A. (2000) Nat. Struct. Biol. 7, 611-613). Because the bound peptide conformation could also differ as observed for peptide ligands bound to the 14-3-3 domain, ligand orientation and conformation for two other biologically relevant monophosphate substrates, one derived from the Cdc25 phosphatase of Xenopus laevis (EQPLpTPVTDL) and another from the human tau protein (KVSVVRpTPPKSPS) in complex with the WW domain are here studied by solution NMR methods. First, the proton resonance perturbations on the WW domain upon complexation with both peptide ligands were determined to be essentially located in the positively charged beta -hairpin Ser11-Gly15 and around the aromatic Trp29. Dissociation equilibrium constants of 117 and 230 µM for Cdc25 and tau peptides, respectively, were found. Several intermolecular nuclear Overhauser effects between WW domain and substrates were obtained from a ligand-saturated solution and were used to determine the structures of the complexes in solution. We found a similar N to C orientation as the one observed in the crystal complex structure of Pin1 and a trans conformation for the pThr-Pro peptidic bond in both peptide ligands, thereby indicating a unique binding scheme for the Pin1 WW domain to its multiple substrates.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Trp-Trp (WW1) domains are compact modules of 38-40 amino acids long, folded into a three-stranded beta  sheet, and found in single or tandem repeats in over 25 unrelated cell-signaling proteins (1, 2). Although their binding to proline-based ligands is now well described (3, 4), little is known about their precise biological function. WW domains form a new family of protein-protein interaction modules targeted to proline residues, analogous to the Src homology (SH) 3 domains (5).

Based on their proline-rich sequence binding specificities, WW domains are classified into five distinct groups (6). The N-terminal WW domain of the peptidyl-prolyl isomerase Pin1, an essential regulator at mitotic entry, is grouped among class IV domains, which bind peptides containing a proline residue preceded by a phosphoserine or a phosphothreonine (pSer/pThr-Pro motif) (7). This latter motif is found in several mitotic Pin1-binding phosphoproteins (8), including the mitotic phosphatase Cdc25 (9, 10) and the microtubule-associated tau (tau ) protein (11).

Site-directed mutagenesis experiments indicate that Pin1 binds phosphoproteins through its N-terminal WW domain and that the binding site mainly implicates the conserved residues Tyr18 and Trp29 (7, 11), which constitute a nearly flat hydrophobic area on the molecular surface of the WW domain. WW domains interacting with the core sequence PPXY, like Yes-associated protein, use the same hydrophobic surface for molecular recognition (3, 4, 12). However, this hydrophobic binding site alone is not likely to explain the phospho-dependent character of the ligand binding to the Pin1 WW domain.

Recently the x-ray crystal structure of the full Pin1 protein bound to a doubly phosphorylated peptide (YpSPTpSPS) from the C-terminal domain (CTD) of RNA polymerase II was reported (13). The protein-peptide interactions are essentially limited to two regions on the WW domain surface. First, a phosphate binding pocket, encompassing the side chains of Ser11, Arg12, and the backbone amide of Arg12, anchors the interacting phosphate moiety via several hydrogen bonds. Second, the aromatic pair Tyr18-Trp29 forms a molecular clamp that constrains the proline at position +1 of the interacting phosphoserine. The peptide ligand binds to the Pin1 WW domain in a N- to C-terminal orientation, in contrast to the C- to N-terminal orientation that is found for two other proline-rich peptides in complex with a group I WW domain (3, 14). Other proline recognition domains, such as the SH3 domain of the Caenorhabditis elegans signaling adaptor protein Sem5, can bind peptidic ligands in both orientations (15). It therefore remains an open question whether the group IV WW domain of Pin1 is capable of binding different ligands in different orientations or whether a unique orientation is preferred.

Furthermore it is of major interest to consider the conformation of the recognized motif and, more specifically, the isomerization state of the peptide bond in the pSer/pThr-Pro motif. In the crystal structure of Pin1 complex (13), the peptide ligand binds with both pSer-Pro peptide bonds in trans conformation. The cis conformation of the peptide would require major rearrangements of the binding site and is therefore not very probable. However, for a related adaptor module, the 14-3-3 domain, a recent crystallography study showed that peptide substrates can be bound with both isomerization states (cis and trans) (16).

Here we have investigated by solution NMR the binding interactions between a synthetic Pin1 WW domain and two biologically relevant monophosphorylated substrates, a Cdc25 peptide model (EQPLpTPVTDL) and a peptide of the tau  protein (KVSVVRpTPPKSPS). Based on the structures of both complexes in solution, we found a similar binding mode as the one observed in the crystal structure of Pin1 bound to a peptide isolated from the CTD of RNA polymerase II (13). This observation gives experimental evidence to a unique binding scheme for Pin1 WW domain to its multiple substrates. Finally, we found the bound peptides to be in a trans conformation and discuss the implication of this aspect in regard of recent data concerning Pin1 molecular function (17).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Peptide Synthesis-- The Pin1 WW domain was obtained by peptide synthesis using the t-butoxycarbonyl-benzyl strategy and the (2,1H-benzotriazolyl-1-yl)-1,1,3,3-tetramethyl uranium hexofluorophosphate in situ activation protocol on an Applied Biosystems 430A peptide synthesizer (Foster City, CA). Side-chain protections were Arg(Tos), Trp(For), Asn(Trt), Gln(Trt), Ser(Bzl), His(Tos), Tyr(Br-Z), Lys(2-CIZ). The formyl group of tryptophan was removed with a solution of 20% piperidine in dimethyl formamide prior to hydrofluoric acid cleavage. After lyophilization, the crude peptide was purified by reverse phase-high pressure liquid chromatography on a Nucleosil C18 (Macherey-Nagel, Duren, Germany) column using a linear gradient of acetonitrile in 0.1% trifluoroacetic acid. Homogene fractions, as checked by reverse phase on an X-terra RP18 (Waters, Milford, MA) and mass spectrometry on a Quattro II electrospray mass spectrometer (Micromass, Manchester, UK), were pooled and lyophilized. The same conditions and procedures were used for WWR12A and WWS11A mutants.

The phosphopeptide sequences, derived from Cdc25 (AcEQPLpTPVTDL) and tau  (AcKVSVVRpTPPKSPS) protein sequences, were previously identified by peptide-scanning experiments as major binding sites for the Pin1 WW domain (7, 11) and were also supplied by peptide synthesis. Peptide chemical synthesis was identical as described (18).

NMR Spectroscopy-- Experiments were performed on a Bruker DMX 600-MHz spectrometer and processed with the Bruker software. Spectra were recorded on a 1 mM sample of the WW domain in a buffer of 50 mM deuterated Tris-HCl, pH 6.4, 100 mM NaCl and at a temperature of 12 °C. Two-dimensional TOCSY (19) and NOESY (20) spectra were acquired with mixing times of 62 and 300 ms, respectively. Spectral widths were 8400 Hz, with 1024 complex points for t2, 256 complex points for t1, 32 transients per increment for TOCSY experiments, and 64 transients for NOESY experiments. The water signal was suppressed using the Watergate (21) or jump-return (22) pulse sequences. The data sets were processed with square sine functions, and zero filling was applied to obtain spectra with a digital resolution of 16.4 Hz/point in the F1 dimension and 8.2 Hz/point in the F2 dimension. The classical homonuclear NMR procedure for resonance assignment in polypeptides was used (23). The stereospecific assignment was assisted by chemical shift calculations (24) computed from the x-ray structure of Pin1 WW domain (Rutgers University Protein Data Bank code 1PIN (25)). Proton chemical shifts were measured in parts per million (ppm) and referenced relative to the methyl proton resonances (put at 0.0 ppm) of the internal standard trimethyl silyl propionate.

NMR Titration-- Increasing amounts of phosphopeptide ligands, with Cdc25 or tau  sequences, were added to a 1 mM sample of WW domain to give molar ratios ranging from 1:0.0 to 1:4.5 for the WW domain-Cdc25 peptide sample or from 1:0.0 to 1:11.0 for the WW domain-tau peptide sample. The pH of each sample was systematically controlled and, if necessary, adjusted to a value of 6.4 by addition of an aliquot of dilute NaOD or DCl solutions. For each titration point, a one-dimensional NMR spectrum was recorded. In addition, two-dimensional NMR TOCSY and NOESY experiments were acquired at low ligand concentration (typically at a ratio of 1:0.5), at equimolar concentration and finally at substrate saturation. For the latter ratio, NOESY spectra with a high number of scans per increment (i.e. 416 and 320, respectively, for the WW domain-Cdc25 and WW domain-tau samples) were acquired, to detect possible weak intermolecular NOEs. The binding constant was calculated by fitting to the following equation,
&Dgr;&dgr;=0.5 &Dgr;&dgr;<SUB><UP>max</UP></SUB>{1+X+K<SUB>d</SUB>/[<UP>WW</UP>]

−[(1+X+K<SUB>d</SUB>/[<UP>WW</UP>])<SUP>2</SUP>−4X]<SUP>1/2</SUP>} (Eq. 1)
where Delta delta is the observed chemical shift, Delta delta max is the maximum shift at ligand saturation, [WW] is the protein concentration, Kd is the dissociation constant, and X is the molar ratio of peptide substrate to protein concentration [WW].

Solution Structure Calculations-- Three-dimensional models of WW domain and of complexes between phosphothreonine peptides and WW domain were determined with interproton restraints derived from NOE spectra. NOEs within the protein and between the protein and ligand were grouped into four distance ranges: 1.8-3.0, 1.8-4.0, 2.0-5.0, and 2.5-6.0 Å, corresponding to strong, medium, weak, and very weak NOEs, respectively. To account for the higher apparent intensity of methyl resonances, 0.5 Å was added to the upper distance limits for NOEs involving methyl protons. Protein backbone hydrogen-bonding restraints (two per hydrogen bond; rHN-O = 1.5-2.5 Å; rN-O = 2.5-3.5 Å) within areas of regular secondary structure were introduced during the final stages of refinement. No torsion angle restraints were used.

The structures were calculated via a hybrid distance geometry/simulated annealing protocol (26) as implemented in the program XPLOR (27). The conformers with no distance violations greater than 0.5 Å and r.m.s. differences for bond and angle deviations from ideality less than 0.01 Å and 2°, respectively, were further submitted to a restrained energy refinement. CVFF was used as a force field in the Discover modules (MSI software) (28), with the experimental intermolecular NOEs used as distance constraints. The minimization procedure consisted of 50 steps of steepest descent followed by steps of Quasi-Newton-Raphson optimization (29) until the maximum energy derivative was lower then 0.05 kcal mol-1 Å-1. Finally, the 20 structures with the lowest overall energies were selected as the representative structures. To compare our results with x-ray structures we used the structure, named the reference structure, whose average r.m.s. deviation with respect to the 19 other structures was minimum. The stereochemical quality of the structures was evaluated by the PROCHECK-NMR program (30).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

NMR Assignment and Structure of the Isolated WW Domain-- Sequence-specific 1H NMR assignments of the WW domain, based on homonuclear TOCSY and NOESY spectra recorded in H2O (23), were straightforward due to the large 1H NMR chemical shifts dispersion observed, ranging from 10.57 ppm for the Hnepsilon 1 of Trp6 to the most upfield resonance for the Hbeta 1 of Asn21 at -0.64 ppm. Chemical shift calculations starting from the WW domain x-ray structure confirmed the atypical resonance frequencies of several protons and indicated the ring current shifts associated with the high number of aromatic residues in the WW domain as the primary source. In particular, the chemical shifts of protons Asn21 Hbeta 1 (-0.64 ppm), Asn21 Hdelta 1 (4.23 ppm), Pro32 Hbeta (0.03 and 0.62 ppm), and Pro32 Hgamma (0.79 and 0.87) showed large upfield shifts due to the ring current effect of the Trp6 indole ring. In the same way the proximity of the aromatic rings of Tyr18 and Tyr19 contributed to the upfield shifts of protons Arg9 Hbeta 1 (0.10 ppm) and Arg31 Halpha (2.68 ppm), respectively.

On the basis of 643 experimental NOE constraints, we derived the solution structure of the WW domain. The structural and energetic statistics on the 20 favorable WW conformers are showed in Table I. The overall fold of the synthetic WW peptide, an antiparallel beta -sheet composed of three beta -strands, was very similar to the x-ray crystallography model (Protein Data Bank code 1PIN (25)), with an r.m.s. backbone deviation of 1.38 Å.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Structural statistics of the 20 favorable conformers

NMR Titration with Ligands-- The binding interaction between phosphothreonine peptides and the WW domain was examined by means of one-dimensional 1H NMR spectra (Fig. 1A). Addition of increasing amounts of peptide ligands caused chemical shift changes for several protons in the WW domain. During the NMR titration some proton resonances, such as the Hn of Arg12 and the Hnepsilon 1 of Trp29, rapidly became broader, until they disappeared from the spectra to reappear at large excess of ligand. This broadening can be ascribed to slow exchange, with the difference in chemical shift for the proton concerned in its free and bound state being of the same order as the exchange rate (31). Other resonances, such as the amide proton of Ser11, moved gradually, whereas many others exhibited practically no chemical shift perturbations. Resonance frequencies for protons of the WW domain were similarly affected upon binding of the Cdc25 and tau  peptide ligands, indicating an equivalent binding mode for both phosphothreonine peptides. The isolated Ser11 amide proton resonance, in rapid exchange on the NMR time scale and hence apparent throughout the titration, was used to estimate a binding constant of 117 and 230 µM for the Cdc25 and tau  phosphopeptides, respectively (Fig. 1B). Finally, the non-phosphorylated variants of peptide ligands did not induce modifications of the WW domain resonances (data not shown), confirming the phospho-dependence of the interaction.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   A, chemical shift changes observed in the amide regions of the 1H NMR spectrum of Pin1 WW domain in presence of increasing amounts (from bottom to top) of Cdc25 phosphopeptides. The extrapolated molar ratio WW domain:ligand and the resonance assignments are indicated. B, titration curve corresponding to chemical shift changes of backbone amide proton of Ser11 (shown by a dotted line in a) was used to calculate the binding constant (see "Experimental Procedures").

NMR Binding Maps-- To obtain a precise description of the complex, two-dimensional NMR spectra of the ligand-saturated WW protein were recorded and completely reassigned. Comparison with the assignments of the free WW domain allowed a precise mapping of the binding surface (Fig. 2). The chemical shift perturbations were essentially grouped in two regions of the WW domain: the loop region between the strands beta 1 and beta 2 (Ser11-Gly15) and the C terminus of the strand beta 3 (Gln28-Glu30). The largest chemical shift changes were observed for the Hnepsilon 1 of Trp29 and the backbone amide proton of Arg12, indicating thereby their presence in the immediate vicinity of the binding site. Noteworthy, an exceptional value of 11.4 ppm was found in the bound form for the resonance of Arg12 backbone amide proton. When displayed on the WW domain surface (Fig. 2), those two most perturbed regions delineated in an unambiguous fashion the phospho-ligand binding site.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Plot of backbone amide chemical shift changes observed for each residue of WW domain in the presence of a large excess of Cdc25 or tau  peptide ligand. The three beta -strands constituting the WW domain fold are shown by arrows. The very large shift (2.10 ppm) of Hn-Arg12 resonance is indicated. On the left side, a ribbon drawing of the WW domain, with residues displaying the largest chemical shifts rendered in detail, is shown. Note that due to some overlapped resonances we were not able to unambiguously assign chemical shifts of Ser13 and Ser14 in the bound form with tau  ligand.

The fact that the WW domain folds into a small compact structure and that only few residues were strongly affected by addition of phosphopeptides suggests that chemical shift changes were caused by direct interaction between the WW domain and peptide ligands and not by some ligand-induced conformational changes. The beta -sheet twist modification upon phosphopeptide complexation, reported from x-ray crystal data (13), appears thus as a minor conformational change during the binding leading to no substantial changes in the pattern of intramolecular NOEs.

Because the key role of Trp29 in the binding feature was previously established for other WW domains (3, 12), we focused on the influence of the loop Ser11-Gly15. Two WW domain mutants, Ser11 right-arrow Ala and Arg12 right-arrow Ala, were synthesized. After confirmation of their structural integrity by circular dichroism and NMR spectra (data not shown), we performed an NMR titration with the Cdc25 phospho-peptide. For both mutants, we observed chemical shift changes upon addition of phosphorylated peptide (Fig. 3), confirming their capacity to bind the Cdc25 peptide. However, chemical shift pertubations were less important, and a 3-fold excess of peptide was not sufficient to drive the Arg12 amide proton resonance of the Ser11 right-arrow Ala WW mutant into the fast exchange regime with concomitant line narrowing (Fig. 3). Therefore, mutations in the loop appeared to weaken the interaction without destroying it completely. The binding affinity between phospho-substrates and Pin1 WW domain seems thus generated by a sum of at least two energetically favorable interactions, the charge-charge interaction between the phosphate group and the positively charged WW loop and the proline-aromatic interaction, with none of the individual interactions appearing as absolutely essential (13).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   1H NMR spectrum of amide regions for wild type WW mutants (bottom), Arg12 right-arrow Ala mutant (middle), and Ser11 right-arrow Ala mutant (top), either in the solution free state (left side) or bound to Cdc25 phosphothreonine peptide (right side) at a protein:ligand molar ratio of 1:3. Chemical shift perturbations for the Hnepsilon 1 of Trp29 and the backbone amide proton of residue 11 are larger in the wild type WW domain then in both mutants.

Conformation of the Bound Peptide-- The conformation of the recognized motif on the peptide ligands and, more specifically, the isomerization state of the peptide bond separating the phospho-residue and proline, is of great interest. We set out to distinguish both isoforms first in the free peptides and then in the complexes. For the tau  peptide, the cis form of the Pro8 following the pThr7 residue could not be detected, in agreement with a recent study that gave an upper limit of 3% for the cis form of the same Pro residue in a somewhat longer peptide that was phosphorylated on Thr7 and Ser11 (32). For the Cdc25 peptide, however, the cis form of Pro6 was clearly detectable, and the complete spin system starting from the delta  protons could be easily assigned for both trans and cis forms (Fig. 4). Upon addition of the WW domain, the spin system of the cis form of this Pro6 did not change, whereas the spin system corresponding to the trans form, which was nine times more intense for the free peptide, completely disappeared due to exchange broadening (Fig. 4). This result clearly shows that the WW domain selects for the pThr-Pro motif with the peptidic bond in the trans conformation.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4.   Spin system of Pro6 of Cdc25 peptide connecting its delta  protons with its beta  and gamma  protons in the free state (top) and in a 1:4.5 complex with WW domain (bottom). The cis (cP6) and trans (tP6) conformations are depicted by dotted lines when detectable.

Intermolecular NOE Data and Complex Structures-- On the basis of NOESY analysis on a ligand-saturated WW sample, 14 and 22 unambiguous protein-ligand NOEs were identified for the Cdc25 and for the tau  peptide, respectively. Contacts with pThr7, Pro8, and Pro9 of the tau  peptide represent intermolecular NOEs that helped to determine the orientation of the peptide ligand in the recognition site of the WW domain. Other intermolecular NOEs were detected between protons of the WW Arg9, Arg12, Phe20, and Trp29 residues and protons of Val5, pThr7, Pro8, and Pro9 of the tau  peptide and the WW Arg12, Tyr18, and Trp29 residues and protons of pThr5, Pro6, and Val7 of the Cdc25 peptide.

These NOEs sets were translated into intermolecular proton-proton distances and formed the basis for construction of the structure of the complexes. Table I gives the structural statistics of the complex models. The WW domain conformation was not significantly modified upon ligand binding, except for a different relative orientation of the loop Ser11-Gly15. This change is brought about by a few distinct intermolecular NOEs observed for the two peptides, which equally induced a slightly different positioning of the peptide ligands on WW domain surface (Figs. 5 and 6). However, besides these small differences, we found a similar N to C orientation of the bound peptides and the same main ligand-protein interactions that could be decomposed into two major contributions (Fig. 6). The WW domain side chain of aromatics Trp29 makes a van der Waals stacking with the conserved proline at position +1 of the interacting phosphothreonine and with hydrophobic residue at +2 (Pro or Val, if one considers tau  or Cdc25 peptides, respectively). The substrate phosphate moiety is bound to the side chain and backbone of Arg12 of the WW domain. The chemical shift perturbations that were observed upon ligand binding by the WW domain were in accordance with this model.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 5.   Stereo view of the overlaid backbone traces of the 20 final conformers of the complex between the Pin1 WW domain and a Cdc25 peptide ligand. Superposition was done on residues (4-32) of the WW domain.


View larger version (147K):
[in this window]
[in a new window]
 
Fig. 6.   Ribbon drawing of the NMR reference structure of the complex between Pin1 WW domain (in light blue) and tau  phosphopeptide ligand (in red), in comparison with the orientation of the CTD peptide (in violet) from the crystallographic model of the complex (13). The image was obtained by backbone superimposition of WW domains from our NMR complex and from the CTD peptide/Pin1 complex (13). Only the WW domain from this study and both phosphopeptide ligands are represented. Side chains implicated into the binding interface are labeled (in white for the WW domain residues and yellow for the ligand residues) and depicted in detail, as well as the amino acid pair Trp6-Pro32 of the WW domain. N atoms are blue and P atoms are violet. C atoms are green in the WW domain and orange in the tau ligand.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The reversible protein phosphorylation on Ser/Thr-Pro motifs acts as an important molecular switch in the cell cycle and is operated by a number of Pro-directed protein kinases (such as Cdc2, Cdk2, Wee1, and Myt1; for a review, see Ref. 33) and phosphatases, such as Cdc25 and PP2A (34, 35). Although atomic level structural data of all substrates in their phosphorylated and non-phosphorylated state are still lacking, one example of the structural influence of phosphorylation is given by Cdk2 itself, where addition of a phosphate group on the Thr160 side chain completes the reorganization of the substrate binding site that was started by cyclin binding (36). A second mechanism of imposing structural changes is brought about by the isomerization of the prolyl peptide bond, and a prolyl cis/trans isomerase, Pin1, has been shown to be essential to achieve a cell cycle (37, 38). A remarkable fact of both Cdk2 and Pin1 is that they associate with small binding modules that are believed to help targeting the catalytic domain more efficiently to their substrates. Cdk2 recruits the CKS, that indeed binds through its anion binding site to the pThr-Pro motif of a Cdc25 peptide (39), whereas human Pin1 contains in its sequence itself already such a binding protein, the WW domain (7, 37). Both functional (40) and structural (39) data indicated a molecular competition of both of binding modules for the same Cdc25 substrate, and this competition indeed might be part of the tight regulation of the cell cycle.

In a related cellular process, both Cdk2 and Pin1 interact with the tau  protein. Cdk2 phosphorylates tau  proteins, in an Alzheimer-like way, leading to microtubule depolymerization (41). Conversely, Pin1 can restore the tubulin polymerization function of these hyperphosphorylated tau  before they aggregate into filaments in Alzheimer neuronal tangles (11). tau  contains about 17 Thr/Ser-Pro motifs, which can all be phosphorylated in the cellular context (42). Amazingly, however, only the tau  pThr131-Pro132 motif was found to be recognized by Pin1, with a high affinity of 40 nM (11). This unusual high affinity for a binding module was not confirmed by our NMR titration data, because we obtained similar dissociation equilibrium constants in the order of 100 µM for both Cdc25 and tau  ligands. Except for differences in methodology, the reason for these differences in Kd values could be due to the fact that we used the isolated WW in our binding experiments, instead of the full-length PIN1. An NMR titration on WW domain-tau peptide samples without 100 mM NaCl yielded an increase of binding affinity (Kd = 29 µM), stressing the importance of ionic strength on the binding affinity of Pin1 related WW domains. Still, considering the ionic concentration in the cell, our calculated Kd appears more relevant, and confirms that the interaction of Pin1 with Cdc25 and tau  are related molecular processes.

Despite the reported selectivity of Pin1, we found that both Cdc25 and tau  phosphopeptides bind to Pin1 WW domains in a similar manner, close to the described binding pattern in the CTD peptide-Pin1 x-ray model (13). However, the crystal complex of the CTD peptide-Pin1 protein shows a larger contact surface between protein and ligand than what was observed in our NMR models. The anchoring zone of the Cdc25 and tau  peptide ligands to the WW domain was only composed of the phospho-residue and residues +1 and +2 (Figs. 5 and 6). We did not observe any significant interaction with the Tyr18 of the WW domain, neither in the chemical shift perturbation assay, nor by the observation of intermolecular NOEs.

The three-dimensional NMR complex model shows that the phosphopeptide ligands are principally fixed by a charge-charge interaction and a proline-aromatic stacking. The participation of the backbone amide group in complexation of the phosphate moiety could explain partly why the mutant Arg12 right-arrow Ala persists to fix ligand. The same argument could help to interpret the phosphopeptide binding properties of other Pin1-related WW domains, such as Nedd4 or Rsp5 proteins, that lack a basic residue in the beta 1-beta 2 loop. In addition, it must be stressed that the intermolecular stacking structure between Trp29 and the proline at position +1 of pThr ligand is analogous to the intramolecular stacking between conserved residues Trp6 and Pro32 of domain WW (Fig. 6). Because several mutagenesis studies (10, 43-45) have established the importance of the Trp6-Pro32 interaction for the folding and the stability of WW domains, we think that a similar strong intermolecular Trp-Pro interaction is used to promote protein-protein interactions between the WW domain and its substrates (46).

The molecular mechanisms of the Pin1 function very recently became clearer through an elegant study by Zhou et al. (17), who showed that Pin1 enhances in vitro the dephosphorylation of Cdc25C by the major transPro-directed phosphatase PP2A. Moreover, they showed that overexpression of the catalytic domain alone can be sufficient for cell survival, whereas at lower levels of expression this is not the case (7). At the molecular level, Pin1 would catalyze the conversion of the cis bond in the pThr-Pro motif of Cdc25C, turning the peptide into a suitable substrate of PP2A. Although direct evidence of such a cis peptide bond in the complete Cdc25 or tau  lacks, their biochemical evidence that Pin1 up-regulates the dephosphorylation of both Cdc25 and tau  convincingly sustains this hypothesis. However, the results of our NMR study unambiguously define the pThr-transPro motif in both Cdc25 and tau  peptide ligands as the binding surface recognized by the Pin1 WW domain, in agreement with the earlier crystal structure of full Pin1 with a doubly phosphorylated CTD peptide (13). Moreover, because our NMR results confirm the absence of interaction between the Pro residue in the cis conformation and the WW domain, it is unlikely that the latter would assist the catalytic domain by targetting it to its pThr/Ser-cisPro substrate, be it on Cdc25, tau  or other protein targets.

The available data can be combined into several scenarios. The WW domain could specifically target Pin1 to the pThr231 of tau  or pThr47 and pThr68 of Cdc25, followed by isomerization of neighboring pThr-Pro bonds through the catalytic domain (47). In another scenario, the catalytic domain could induce the conformational transition from cis to trans of the pThr-Pro motif prior to any WW binding. Before a return to the cis/trans equilibrium situation, the WW domain could then immediately bind to the pThr-trans conformation, thereby stabilizing this conformation and simultaneously increasing the local concentration of Pin1. Both scenarios solve the dilemma that the WW domain has an at least 10-fold higher affinity as does the catalytic domain for the same substrates (7, 13) and, consequently, would bind first to the epitope before catalysis could happen. Further studies will be necessary to investigate this possibility of prolyl cis/trans isomerization anterior to WW binding.

    ACKNOWLEDGEMENTS

We thank A. Kasprowiak, J.-S. Fruchart, and C. Smet for peptide synthesis. We also thank Dr. E. Buisine for useful assistance with the molecular modeling program InsightII.

    FOOTNOTES

* This project was partly executed in the framework of the Génopole de Lille. The 600-MHz NMR facility used in this study was funded by the European community, the Région Nord-Pas de Calais, CNRS, and the Institut Pasteur de Lille.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The 1H resonances of Pin1 WW domain have been deposited in the BioMagResBank (available on the Web) under BMRB accession number 4882. The coordinates of the 10 best conformers are deposited in the Rutgers Protein Data Bank under accession codes 1I6C for the WW domain, 1I8G for the complex Cdc25 peptide/domain WW, and 1I8H for the complex tau  peptide/domain WW.

To whom correspondence may be addressed: Tel.: 33-3-20-87-12-29; Fax: 33-3-20-87-12-33; E-mail: Guy.Lippens@pasteur-lille.fr or Isabelle.Landrieu{at}pasteur-lille.fr.

Published, JBC Papers in Press, April 19, 2001, DOI 10.1074/jbc.M010327200

    ABBREVIATIONS

The abbreviations used are: WW, Trp-Trp domain; CTD, C-terminal domain of RNA polymerase II; NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser effect spectroscopy; pSer/pThr or pS/pT, phosphoserine/phosphothreonine; r.m.s., root mean square; TOCSY, total correlation spectroscopy; SH, Src homology.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Bork, P., and Sudol, M. (1994) Trends Biochem. Sci. 19, 531-533[CrossRef][Medline] [Order article via Infotrieve]
2. Staub, O., and Rotin, D. (1996) Structure 4, 495-499[Medline] [Order article via Infotrieve]
3. Macias, M. J., Hyvönen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., and Oschkinat, H. (1996) Nature 382, 646-649[CrossRef][Medline] [Order article via Infotrieve]
4. Chen, H. I., Einbond, A., Kwak, S.-J., Linn, H., Koepf, E., Peterson, S., Kelly, J. W., and Sudol, M. (1997) J. Biol. Chem. 272, 17070-17077[Abstract/Free Full Text]
5. Kay, B. K., Williamson, M. P., and Sudol, M. (2000) FASEB J. 14, 231-241[Abstract/Free Full Text]
6. Bedford, M., Sarbassova, D., Xu, J., Leder, P., and Yaffe, M. B. (2000) J. Biol. Chem. 275, 10359-10369[Abstract/Free Full Text]
7. Lu, P.-J., Zhou, X. Z., Shen, M., and Lu, K. P. (1999) Science 283, 1325-1328[Abstract/Free Full Text]
8. Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J.-U., Xu, J., Kuang, J., Kirschner, M. W., Fischer, G., Cantley, L. C., and Lu, K. P. (1997) Science 278, 1957-1960[Abstract/Free Full Text]
9. Shen, M., Stukenberg, P. T., Kirschner, M. W., and Lu, K. P. (1998) Genes Dev. 12, 706-720[Abstract/Free Full Text]
10. Crenshaw, D. G., Yang, J., Means, A. R., and Kornbluth, S. (1998) EMBO J. 17, 1315-1327[Abstract/Free Full Text]
11. Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., and Lu, K. P. (1999) Nature 399, 784-788[CrossRef][Medline] [Order article via Infotrieve]
12. Koepf, E. K., Petrassi, H. M., Ratnaswamy, G., Huff, M. E., Sudol, M., and Kelly, J. W. (1999) Biochemistry 38, 14338-14351[CrossRef][Medline] [Order article via Infotrieve]
13. Verdecia, M. A., Bowman, M. E., Lu, K. P., Hunter, T., and Noel, J. P. (2000) Nat. Struct. Biol. 7, 639-643[CrossRef][Medline] [Order article via Infotrieve]
14. Huang, X., Poy, F., Zhang, R., Joachimiak, A., Sudol, M., and Eck, M. J. (2000) Nat. Struct. Biol. 7, 634-638[CrossRef][Medline] [Order article via Infotrieve]
15. Zarrinpar, A., and Lim, W. A. (2000) Nat. Struct. Biol. 7, 611-613[CrossRef][Medline] [Order article via Infotrieve]
16. Rittinger, K., Budman, J., Xu, J., Volinia, S., Cantley, L. C., Smerdon, S. J., Gamblin, S. J., and Yaffe, M. B. (1999) Mol. Cell 4, 153-166[Medline] [Order article via Infotrieve]
17. Zhou, X. Z., Kops, O., Werner, A., Lu, P.-J., Shen, M., Stoller, G., Küllertz, G., Stark, M., Fischer, G., and Lu, K. P. (2000) Mol. Cell 6, 873-883[Medline] [Order article via Infotrieve]
18. Landrieu, I., De Veylder, L., Fruchart, J.-S., Odaert, B., Casteels, P., Portetelle, D., Van Montagu, M., Inzé, D., and Lippens, G. (2000) J. Biol. Chem. 275, 10577-10581[Abstract/Free Full Text]
19. Bax, A., and David, D. (1985) J. Magn. Reson. 53, 521-528
20. Jeener, J., Meier, B. H., Bachmann, P., and Ernst, R. R. (1979) J. Chem. Phys. 71, 4546-4553[CrossRef]
21. Piotto, M., Saudek, V., and Sklenar, V. (1992) J. Biomol. NMR 2, 661-665[Medline] [Order article via Infotrieve]
22. Plateau, P., and Guéron, M. (1982) J. Am. Chem. Soc. 104, 7310-7311
23. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids , pp. 130-175, Wiley Press, New York
24. Williamson, M. P., Kikuchi, J., and Asakura, T. (1995) J. Mol. Biol. 247, 541-546[CrossRef][Medline] [Order article via Infotrieve]
25. Ranganathan, R., Lu, K. P., Hunter, T., and Noel, J. P. (1997) Cell 89, 875-886[Medline] [Order article via Infotrieve]
26. Nilges, M., Clore, G. M., and Gronenborn, A. M. (1988) FEBS Lett. 229, 129-136
27. Brünger, A. T. (1993) XPLOR Manual, Version 3.1 , Yale University, New Haven, CT
28. Maple, J., Dinur, U., and Hagler, A. T. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5350-5354[Abstract]
29. Fletcher, R. (1980) Practical Methods of Optimization , Vol. 1 , John Wiley & Sons, New York
30. Laskowski, R. A., McArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef]
31. Kaplan, J. I. (1995) in Encyclopedia in Nuclear Magnetic Resonance (Grant, D. M. , and Harris, R. K., eds), Vol. 2 , pp. 1247-1256, John Wiley and Sons, New York
32. Daly, N. L., Hoffmann, R., Otvos, L., and Craik, D. J. (2000) Biochemistry 39, 9039-9046[CrossRef][Medline] [Order article via Infotrieve]
33. Morgan, D. O. (1995) Nature 374, 131-134[CrossRef][Medline] [Order article via Infotrieve]
34. Dunphy, W. G., and Kumagai, A. (1991) Cell 67, 189-196[Medline] [Order article via Infotrieve]
35. Karaiskou, A., Jessus, C., Brassac, T., and Ozon, R. (1999) J. Cell Sci. 112, 3747-3756[Abstract/Free Full Text]
36. Russo, A. A., Jeffrey, P. D., and Pavletich, N. P. (1996) Nat. Struct. Biol. 3, 696-700[Medline] [Order article via Infotrieve]
37. Lu, K. P., Hanes, S. D., and Hunter, T. (1996) Nature 380, 544-547[CrossRef][Medline] [Order article via Infotrieve]
38. Winkler, K. E., Swenson, K. I., Kornbluth, S., and Means, A. R. (2000) Science 287, 1644-1647[Abstract/Free Full Text]
39. Landrieu, I., Odaert, B., Wieruszeski, J.-M., Drobecq, H., Rousselot-Pailley, P., Inzé, D., and Lippens, G. (2001) J. Biol. Chem. 276, 1434-1438[Abstract/Free Full Text]
40. Patra, D., Wang, S. X., Kumagai, A., and Dunphy, W. G. (1999) J. Biol. Chem. 274, 36839-36842[Abstract/Free Full Text]
41. Baumann, K., Mandelkow, E. M., Biernat, J., Piwnica-Worms, H., and Mandelkow, E. (1993) FEBS lett. 336, 417-424[CrossRef][Medline] [Order article via Infotrieve]
42. Delacourte, A., and Buée, L. (1997) Int. Rev. Cytol. 171, 167-224[Medline] [Order article via Infotrieve]
43. Koepf, E. K., Petrassi, H. M., Sudol, M., and Kelly, J. W. (1999) Prot. Sci. 8, 841-853[Abstract]
44. Crane, J. C., Koepf, E. K., Kelly, J. W., and Gruebele, M. (2000) J. Mol. Biol. 298, 283-292[CrossRef][Medline] [Order article via Infotrieve]
45. Macias, M. J., Gervais, V., Civera, C., and Oschkinat, H. (2000) Nat. Struct. Biol. 7, 375-379[CrossRef][Medline] [Order article via Infotrieve]
46. Shoemaker, B. A., Portman, J. J., and Wolynes, P. G. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8868-8873[Abstract/Free Full Text]
47. Zhou, X. Z., Lu, P.-J., Wulf, G., and Lu, K. P. (1999) Cell. Mol. Life Sci. 56, 788-806[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.